Institutional investors hold a majority ownership of GILD through the 81.64% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended June 2019, these large investors purchased a net $17.3 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
DODGE & COX Bought 10.5 Million shares of Gilead Sciences Inc
PARNASSUS INVESTMENTS Bought 4.9 Million shares of Gilead Sciences Inc
AMUNDI ASSET MANAGEMENT US, INC. Bought 4.7 Million shares of Gilead Sciences Inc